 The purpose of this trial is to compare two different treatment options for patients with low risk and low-tier intermediate risk prostate cancer. The two treatment arms being compared in this study are: control arm permanent interstitial prostate brachytherapy PIPB VERSUS experimental arm intensity modulated external beam radiation therapy IMRT. 